SG Americas Securities, LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 171 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q1 2023$24
-75.8%
14,994
-6.1%
0.00%
-100.0%
Q4 2022$99
-100.0%
15,969
-80.7%
0.00%
-85.7%
Q3 2022$555,000
+41.6%
82,889
+34.6%
0.01%
+75.0%
Q2 2022$392,000
-29.1%
61,583
-44.3%
0.00%
+33.3%
Q4 2021$553,000
-54.8%
110,514
+8.8%
0.00%
-50.0%
Q3 2021$1,224,000
+317.7%
101,580
+633.7%
0.01%
+500.0%
Q2 2021$293,000
-35.7%
13,844
-14.9%
0.00%
-50.0%
Q1 2021$456,000
+12.9%
16,266
+4.6%
0.00%0.0%
Q4 2020$404,000
-54.4%
15,549
-34.7%
0.00%
-66.7%
Q3 2020$885,000
+218.3%
23,819
+340.0%
0.01%
+200.0%
Q2 2020$278,000
-68.1%
5,414
-80.4%
0.00%
-75.0%
Q1 2020$872,000
-28.9%
27,652
+34.5%
0.01%
-27.3%
Q4 2019$1,226,000
+105.7%
20,563
+38.6%
0.01%
+120.0%
Q1 2019$596,000
+193.6%
14,840
+236.9%
0.01%
+150.0%
Q4 2018$203,000
-81.0%
4,405
-83.9%
0.00%
-80.0%
Q2 2018$1,071,000
-83.7%
27,319
-70.0%
0.01%
-81.1%
Q1 2018$6,580,000
+3206.5%
90,973
+2909.4%
0.05%
+2550.0%
Q4 2017$199,000
+15.7%
3,023
-11.7%
0.00%0.0%
Q3 2017$172,000
-46.9%
3,423
-51.2%
0.00%
-33.3%
Q2 2017$324,000
+128.2%
7,008
+74.5%
0.00%
+200.0%
Q1 2017$142,000
+40.6%
4,017
-50.2%
0.00%0.0%
Q4 2016$101,000
-72.5%
8,062
+79.7%
0.00%
-50.0%
Q2 2015$367,0004,4870.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q4 2022
NameSharesValueWeighting ↓
Meditor Group Ltd 2,679,835$69,675,00019.39%
Endurant Capital Management LP 207,293$5,390,0001.94%
Bellevue Group AG 5,138,451$133,599,0001.53%
Rhenman & Partners Asset Management AB 592,225$15,398,0001.26%
PLATINUM INVESTMENT MANAGEMENT LTD 1,562,869$40,635,0000.93%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 31,434$817,0000.62%
WASATCH ADVISORS LP 3,998,010$103,949,0000.51%
HAMILTON LANE ADVISORS LLC 46,181$1,201,0000.45%
Boxer Capital, LLC 500,000$13,000,0000.42%
DCF Advisers, LLC 38,500$1,001,0000.41%
View complete list of ESPERION THERAPEUTICS INC NE shareholders